Oversold Stocks — Overview View · Biological Products, (No Diagnostic Substances)
5 stocks match the Oversold Stocks screen. Stocks with an RSI (14) below 30 — technically oversold, most-oversold first. Overview columns. Filtered to Biological Products, (No Diagnostic Substances). Updated
Filters2
1–5 of 5
| TCRX | TScan Therapeutics, Inc. | Healthcare | Biological Products, (No Diagnostic Substances) | $48M | -0.41 | 0.37 | -5.08% | Sell | 61K |
| CRIS | CURIS INC | Healthcare | Biological Products, (No Diagnostic Substances) | $3M | -0.13 | 1.36 | -2.16% | Sell | 2K |
| SLXN | Silexion Therapeutics Corp | Healthcare | Biological Products, (No Diagnostic Substances) | $2M | -0.14 | 0.35 | -0.03% | Sell | 1K |
| DYAI | DYADIC INTERNATIONAL INC | Healthcare | Biological Products, (No Diagnostic Substances) | $18M | -2.41 | 0.50 | -4.92% | Sell | 10K |
| SCLX | Scilex Holding Co | Healthcare | Biological Products, (No Diagnostic Substances) | $45M | -0.10 | 5.31 | -0.56% | Sell | 2K |
Source: SEC EDGAR/XBRL (fundamentals, shares) · Databento EQUS.MINI (EOD prices) · multiples, ratios & technicals computed by tradmap. Financials reflect the latest reported annual period. Informational only — not financial advice.